Treating two concurrent B-cell and T-cell lymphoid neoplasms with alemtuzumab monotherapy

Author： Bolli N.   Di Ianni M.   Simonetti S.   Cerroni L.   Liso A.   Falini B.   Tabilio A.  

Publisher： Elsevier

ISSN： 1470-2045

Source： Lancet Oncology, Vol.5, Iss.1, 2004-01, pp. : 64-65

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Alemtuzumab in CLL and Other Lymphoid Neoplasms

By Ravandi Farhad   O'Brien Susan  

Cancer Investigation, Vol. 24, Iss. 7, 2006-09 ,pp. : 718-725

Informa Healthcare

Access to resources Recommend Favorite

PAX5 and B-cell neoplasms: transformation through presentation

By Thomas-Tikhonenko Andrei   Cozma Diana  

Future Oncology, Vol. 4, Iss. 1, 2008-02 ,pp. : 5-9

Future Medicine

Access to resources Recommend Favorite

Alemtuzumab therapy for severe autoimmune hemolysis in a patient with B-cell chronic lymphocytic leukemia

By Lundin Jeanette   Karlsson Claes   Celsing Fredrik  

Medical Oncology, Vol. 23, Iss. 1, 2006-03 ,pp. : 137-139

Humana Press, Inc

Access to resources Recommend Favorite

T-cell acute lymphoid leukemia resembling Burkitt leukemia cell morphology: A case report

By  

Oncology Letters, Vol. 9, Iss. 3, 2015-01 ,pp. : 1236-1238

Spandidos Publications

Access to resources Recommend Favorite

The role of cell traffic in the emergence of the T lymphoid system

By Dunon D.   Imhof B.A.  

Seminars in Immunology, Vol. 12, Iss. 5, 2000-10 ,pp. : 429-433

Academic Press

Access to resources Recommend Favorite